Centessa Pharmaceuticals plc (NASDAQ: CNTA)
$15.3600
+0.5200 ( +1.59% ) 62.3K
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include 1) SerpinPC for Hemophilia A, B, 2) LB101 for Solid Tumors, 3) ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders, 4) MGX292 Pulmonary Arterial Hypertension (PAH) and 5) Undisclosed for Solid Tumors.
Market Data
Open
$15.3600
Previous close
$14.8400
Volume
62.3K
Market cap
$2.00B
Day range
$14.8200 - $15.4600
52 week range
$6.9500 - $18.9700
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 8-k | 8K-related | 40 | Jan 08, 2025 |
| 4 | Insider transactions | 1 | Dec 31, 2024 |
| 4 | Insider transactions | 1 | Dec 31, 2024 |
| 4 | Insider transactions | 1 | Dec 31, 2024 |
| 4 | Insider transactions | 1 | Dec 31, 2024 |
| 4 | Insider transactions | 1 | Dec 31, 2024 |
| 4 | Insider transactions | 1 | Dec 26, 2024 |
| 4 | Insider transactions | 1 | Dec 20, 2024 |
| 4 | Insider transactions | 1 | Dec 17, 2024 |
| 4 | Insider transactions | 1 | Dec 17, 2024 |